Organovo

Organovo

Employees:
110
Market Cap:
$206.63 million
Revenue:
$4.12 million
5 Year Trend:
8.9%
Net Income:
$-38.94 million
NASDAQ:
ONVO

Organovo is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue (also known as 3D bioprinting technology) for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. Wikipedia

Organovo

Employees:
110
Market Cap:
$206.63 million
Revenue:
$4.12 million
5 Year Trend:
8.9%
Net Income:
$-38.94 million
NASDAQ:
ONVO

Organovo is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue (also known as 3D bioprinting technology) for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. Wikipedia

Jul 14, 10:40 PM

Thank you CA Biotechnology Committee and Chair Kevin Mullin for spending time with us today. 3D bioprinted tissues help speed safer drugs to patients and create regenerative medicine therapies. CLSA - California Life Sciences Association

Jun 22, 6:55 PM

Great panel discussion yesterday at #BIO2017 on global #RegenMed regulatory approval pathways. Patients are sure to benefit from shared interests and collaboration to bring safe, first in class tissue engineered therapies to market. Big thank you to Barbara Freischem, Noam Levey, Keith Murphy, and Celia Witten for your time and insight.

Jun 14, 4:53 PM

Organovo at the World Preclinical Congress this week. If you missed our luncheon presentation, stop by booth 512 to learn more about our preclinical testing and disease modeling services #CHIWPC17

Jun 5, 0:22 PM

Organovo to present at Jefferies Healthcare Conference - http://bit.ly/2rWh1BO